ad board

Partner Content

Partner Content

“Very satisfied” is the consensus of KOLs who participate in our SkyBoard virtual advisory board events.

News

A $100m trial has been launched to see if lifestyle changes coupled with GLP-1 agonists or similar incretins can reduce the risk of dementia.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.